TNFRSF8 and Hodgkins lymphoma: The recognition of the CD30 extracellular portion was evaluated by flow cytometry on the human Hodgkin’s lymphoma CD30+ AH-HLH 200 cell line, showing an equal CD30 positivity among all newly generated and BER-H2 anti-CD30 clones (Figure 1D).